000 | 01870 a2200517 4500 | ||
---|---|---|---|
005 | 20250515062146.0 | ||
264 | 0 | _c20070703 | |
008 | 200707s 0 0 eng d | ||
022 | _a0001-5172 | ||
024 | 7 |
_a10.1111/j.1399-6576.2006.01252.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSalluh, J I F | |
245 | 0 | 0 |
_aEarly use of terlipressin in catecholamine-resistant shock improves cerebral perfusion pressure in severe traumatic brain injury. _h[electronic resource] |
260 |
_bActa anaesthesiologica Scandinavica _cApr 2007 |
||
300 |
_a505-8 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAccidents, Traffic |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aBrain Injuries _xcomplications |
650 | 0 | 4 |
_aCatecholamines _xadministration & dosage |
650 | 0 | 4 |
_aCerebrovascular Circulation _xdrug effects |
650 | 0 | 4 | _aDrug Resistance |
650 | 0 | 4 | _aFatal Outcome |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLypressin _xanalogs & derivatives |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMotorcycles |
650 | 0 | 4 |
_aMultiple Organ Failure _xetiology |
650 | 0 | 4 |
_aNorepinephrine _xadministration & dosage |
650 | 0 | 4 |
_aOxygen _xblood |
650 | 0 | 4 |
_aRespiratory Distress Syndrome _xetiology |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aShock _xcomplications |
650 | 0 | 4 |
_aSystemic Inflammatory Response Syndrome _xcomplications |
650 | 0 | 4 | _aTerlipressin |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVasoconstrictor Agents _xtherapeutic use |
700 | 1 | _aMartins, G A R | |
700 | 1 | _aSantino, M S | |
700 | 1 | _aAraújo, L V | |
700 | 1 | _aFreitas, G G | |
700 | 1 | _aVerdeal, J C R | |
773 | 0 |
_tActa anaesthesiologica Scandinavica _gvol. 51 _gno. 4 _gp. 505-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1399-6576.2006.01252.x _zAvailable from publisher's website |
999 |
_c16933465 _d16933465 |